HS
LLY icon

HighVista Strategies’s Eli Lilly LLY Stock Holding History

HighVista Strategies’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,500
Closed -$1.33M – 159
2024
Q3 		$1.33M Hold
1,500
– – 0.46% 90
2024
Q2 		$1.36M Buy
+1,500
New +$1.2M 0.5% 77
2024
Q1 		– Sell
-2,300
Closed -$1.34M – 145
2023
Q4 		$1.34M Buy
2,300
+900
+64% +$525K 0.49% 69
2023
Q3 		$752K Buy
+1,400
New +$721K 0.35% 69
2018
Q1 		– Sell
-4,400
Closed -$372K – 208
2017
Q4 		$372K Sell
4,400
-1,600
-27% -$136K 0.1% 152
2017
Q3 		$513K Buy
+6,000
New +$492K 0.12% 123
2014
Q4 		– Sell
-3,598
Closed -$233K – 175
2014
Q3 		$233K Buy
+3,598
New +$228K 0.03% 140

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HighVista Strategies's LLY Position: Q4 2024 in Review

HighVista Strategies sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 1,500 shares — an estimated $1.33M sold.

HighVista Strategies first reported a position in LLY in Q3 2014 and held it in 7 quarters. The position peaked at $1.36M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • HighVista Strategies reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • HighVista Strategies sold 1,500 Eli Lilly shares in Q4 2024, an estimated $1.33M.
  • HighVista Strategies first reported a position in Eli Lilly in Q3 2014 and held it in 7 quarters.
  • HighVista Strategies's Eli Lilly position peaked at $1.36M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on HighVista Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.